These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15894682)

  • 21. Cyp17 promoter variant associated with prostate cancer aggressiveness in African Americans.
    Kittles RA; Panguluri RK; Chen W; Massac A; Ahaghotu C; Jackson A; Ukoli F; Adams-Campbell L; Isaacs W; Dunston GM
    Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):943-7. PubMed ID: 11535545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic variation in CYP3A43 explains racial difference in olanzapine clearance.
    Bigos KL; Bies RR; Pollock BG; Lowy JJ; Zhang F; Weinberger DR
    Mol Psychiatry; 2011 Jun; 16(6):620-5. PubMed ID: 21519338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New genetic variant that might improve warfarin dose prediction in African Americans.
    Schelleman H; Brensinger CM; Chen J; Finkelman BS; Rieder MJ; Kimmel SE
    Br J Clin Pharmacol; 2010 Sep; 70(3):393-9. PubMed ID: 20716240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin D Pathway and Other Related Polymorphisms and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial.
    Torkko K; Till C; Tangen CM; Goodman PJ; Song X; Schenk JM; Lucia MS; Peters U; van Bokhoven A; Thompson IM; Neuhouser ML
    Cancer Prev Res (Phila); 2020 Jun; 13(6):521-530. PubMed ID: 32102946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sex steroid hormones in young manhood and the risk of subsequent prostate cancer: a longitudinal study in African-Americans and Caucasians (United States).
    Tsai CJ; Cohn BA; Cirillo PM; Feldman D; Stanczyk FZ; Whittemore AS
    Cancer Causes Control; 2006 Dec; 17(10):1237-44. PubMed ID: 17111254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tobacco carcinogen-detoxifying enzyme UGT1A7 and its association with orolaryngeal cancer risk.
    Zheng Z; Park JY; Guillemette C; Schantz SP; Lazarus P
    J Natl Cancer Inst; 2001 Sep; 93(18):1411-8. PubMed ID: 11562393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of early-onset prostate cancer in relation to germ line polymorphisms of the vitamin D receptor.
    Oakley-Girvan I; Feldman D; Eccleshall TR; Gallagher RP; Wu AH; Kolonel LN; Halpern J; Balise RR; West DW; Paffenbarger RS; Whittemore AS
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1325-30. PubMed ID: 15298953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of RNASEL variants with prostate cancer risk in Hispanic Caucasians and African Americans.
    Shook SJ; Beuten J; Torkko KC; Johnson-Pais TL; Troyer DA; Thompson IM; Leach RJ
    Clin Cancer Res; 2007 Oct; 13(19):5959-64. PubMed ID: 17908993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A polymorphism of the 5 alpha-reductase gene and its association with prostate cancer: a case-control analysis.
    Kantoff PW; Febbo PG; Giovannucci E; Krithivas K; Dahl DM; Chang G; Hennekens CH; Brown M; Stampfer MJ
    Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):189-92. PubMed ID: 9138662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Associations between the MDM2 promoter P1 polymorphism del1518 (rs3730485) and incidence of cancer of the breast, lung, colon and prostate.
    Gansmo LB; Vatten L; Romundstad P; Hveem K; Ryan BM; Harris CC; Knappskog S; Lønning PE
    Oncotarget; 2016 May; 7(19):28637-46. PubMed ID: 27081698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A common CYP1B1 polymorphism is associated with 2-OHE1/16-OHE1 urinary estrone ratio.
    Paracchini V; Pedotti P; Raimondi S; Garte S; Bradlow HL; Sepkovic DW; Taioli E
    Clin Chem Lab Med; 2005; 43(7):702-6. PubMed ID: 16207128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peroxisome proliferator-activated receptor-gamma polymorphism, body mass and prostate cancer risk: evidence for gene-environment interaction.
    Zmuda JM; Modugno F; Weissfeld JL; Cauley JA; Trump DL; Moffett SP; Ferrell RE
    Oncology; 2006; 70(3):185-9. PubMed ID: 16763406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-gamma 2 is associated with combined hyperlipidaemia in obesity.
    Swarbrick MM; Chapman CM; McQuillan BM; Hung J; Thompson PL; Beilby JP
    Eur J Endocrinol; 2001 Mar; 144(3):277-82. PubMed ID: 11248748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness.
    Neslund-Dudas C; Bock CH; Monaghan K; Nock NL; Yang JJ; Rundle A; Tang D; Rybicki BA
    Prostate; 2007 Nov; 67(15):1654-63. PubMed ID: 17823934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional variant of manganese superoxide dismutase (SOD2 V16A) polymorphism is associated with prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer study.
    Kang D; Lee KM; Park SK; Berndt SI; Peters U; Reding D; Chatterjee N; Welch R; Chanock S; Huang WY; Hayes RB
    Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1581-6. PubMed ID: 17646272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased risk of bladder cancer associated with a glutathione peroxidase 1 codon 198 variant.
    Ichimura Y; Habuchi T; Tsuchiya N; Wang L; Oyama C; Sato K; Nishiyama H; Ogawa O; Kato T
    J Urol; 2004 Aug; 172(2):728-32. PubMed ID: 15247771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A race-specific genetic polymorphism in the CYP1A1 gene is not associated with lung cancer in African Americans.
    Kelsey KT; Wiencke JK; Spitz MR
    Carcinogenesis; 1994 Jun; 15(6):1121-4. PubMed ID: 8020143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between germline variation in the FHIT gene and prostate cancer in Caucasians and African Americans.
    Levin AM; Ray AM; Zuhlke KA; Douglas JA; Cooney KA
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1294-7. PubMed ID: 17548701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans.
    Haiman CA; Chen GK; Blot WJ; Strom SS; Berndt SI; Kittles RA; Rybicki BA; Isaacs WB; Ingles SA; Stanford JL; Diver WR; Witte JS; Chanock SJ; Kolb S; Signorello LB; Yamamura Y; Neslund-Dudas C; Thun MJ; Murphy A; Casey G; Sheng X; Wan P; Pooler LC; Monroe KR; Waters KM; Le Marchand L; Kolonel LN; Stram DO; Henderson BE
    PLoS Genet; 2011 May; 7(5):e1001387. PubMed ID: 21637779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CYP1B1 variants are associated with prostate cancer in non-Hispanic and Hispanic Caucasians.
    Beuten J; Gelfond JA; Byrne JJ; Balic I; Crandall AC; Johnson-Pais TL; Thompson IM; Price DK; Leach RJ
    Carcinogenesis; 2008 Sep; 29(9):1751-7. PubMed ID: 18544568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.